AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
48.38
+0.41 (0.85%)
Nov 10, 2026, 4:00 PM EST - Market closed
AnaptysBio Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $52 → $95 | Buy | Reiterates | $52 → $95 | +96.36% | Oct 26, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $81 | Buy | Maintains | $81 | +67.42% | Oct 22, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates $70 → $60 | Buy | Reiterates | $70 → $60 | +24.02% | Sep 30, 2026 |
| Barclays | Barclays | Buy Maintains $75 | Buy | Maintains | $75 | +55.02% | Sep 23, 2026 |
| UBS | UBS | Buy Reiterates $76 | Buy | Reiterates | $76 | +57.09% | Sep 22, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 24, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $93 | Buy | Maintains | $93 | +92.23% | Jul 21, 2026 |